Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01835756 · ClinicalTrials.gov registry record · NA

Study of Low Level Laser Therapy to Treat Low Back Pain

A NA study of Low Back Pain, sponsored by Erchonia Corporation.

Completed
Registry status
NA
Development phase
62
Enrollment target
2
Study locations

NCT01835756 is a NA study of Low Back Pain that has completed, run by Erchonia Corporation. The registered enrollment target is 62 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01835756, a NA study of Low Back Pain, has completed, sponsored by Erchonia Corporation.

COMPLETED
Registry status
NA
Development phase
62 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine whether the Erchonia® ML Scanner (MLS) is effective in the treatment of acute minor episodic chronic low back pain of musculoskeletal origin.

Conditions Studied

Interventions

  • DEVICE Placebo Laser
  • DEVICE Erchonia MLS

Study Locations (2)

Arizona

  • South Mountain Chiropractic Center - Chandler
  • Mark B. Burdorf DC - Scottsdale

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2012-09
Est. Completion 2014-09
Phase NA

Sponsor

Erchonia Corporation

34 total trials

What the Registry Record Tells You About NCT01835756

The ClinicalTrials.gov registry entry for NCT01835756 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (88% lower). The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo Laser is the first listed.

NCT01835756 reports 2 study locations spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT01835756 about?

NCT01835756 is a clinical study titled "Study of Low Level Laser Therapy to Treat Low Back Pain". The purpose of this study is to determine whether the Erchonia® ML Scanner (MLS) is effective in the treatment of acute minor episodic chronic low back pain of musculoskeletal origin.

What is the current status of trial NCT01835756?

This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2012-09. Estimated completion is 2014-09.

What conditions does trial NCT01835756 study?

This clinical trial studies the following conditions: Low Back Pain.

What interventions are being tested in trial NCT01835756?

The interventions under investigation include: Placebo Laser (DEVICE), Erchonia MLS (DEVICE).

Who is sponsoring clinical trial NCT01835756?

This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01835756 being conducted?

This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.